To Get Help Now
Click Here
 
Today's Date:

Plavix, Pradax Confusion Raises Concerns Health Canada

AddThis Social Bookmark Button

Boehringer Ingelheim (Canada) Ltd., and Sanofi-Aventis Canada Inc., have joined Health Canada to raise awareness regarding the risk of medication mix-ups with the drugs Plavix (clopidogrel) and Pradax (dabigatran). Five mix-ups have been reported in Canada.

Dabigatran is sold as Pradaxa in the U.S.

Plavix is a medication that helps blood platelets from sticking together to form clots, while Pradax is a blood thinner used by patients who have irregular heartbeat. Health Canada says that receiving one medication instead of the other can cause harm, including blood clots, heart attack, bleeding, and stroke.

Health Canada is advising that patients and caregivers make sure they can read any prescription clearly, and that they know and understand why a medication is prescribed. Health Canada also advises that anyone who takes a medication should talk to the pharmacists when picking up a prescription, and raise questions if a medication looks different than normal.

Any medication mix-ups, or adverse reactions caused by a medication mix-up should be reported to:

Plavix Issues
sanofi-aventis Canada Inc.
2150 St-Elzear Blvd. West
Laval, Quebec H7L 4A8
Phone: 1-800-265-7927

Pradax Issues
Boehringer Ingelheim (Canada) Ltd.,
5180 south Service Rd,
Burlington, ON L7L 5H4
Tel: 1 (800) 263-5103 Ext. 84603.
http://www.boehringer-ingelheim.ca/en/contact.html

 

breakinglawsuitnews.com disclaimer: This article: Plavix, Pradax Confusion Raises Concerns Health Canada was posted on Thursday, November 10th, 2011 at 11:25 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.